News
INmune Bio To Join Russell 3000 Index, Effective At The Open Of Us Equity Markets On Monday, July 1
30 May 24
Biotech, News, General
INmune Bio Q1 2024 GAAP EPS $(0.61) Misses $(0.54) Estimate, Sales $14.000K Miss $30.000K Estimate
9 May 24
Earnings, Earnings Misses, News
INmune Bio Inc. Presents Data On INB03's Role As An Immune Check Point Modulator In The Treatment Of High-Risk Breast Cancer At AACR 2024
8 Apr 24
Biotech, News, General
INmune Bio: Q4 Earnings Insights
28 Mar 24
Earnings
INmune Bio Q4 EPS $(0.47) Misses $(0.44) Estimate, Sales $28.00K Miss $40.00K Estimate
28 Mar 24
Earnings, News
Earnings Scheduled For March 28, 2024
28 Mar 24
Earnings
A Preview Of INmune Bio's Earnings
27 Mar 24
Earnings
Press releases
INmune Bio Inc. to Join Russell 3000® Index
30 May 24
Press Releases
INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
9 May 24
Earnings, Press Releases
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28
26 Mar 24
Press Releases